ENGLISH

Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

By Institute of Medicine , Sally Robinson , Development , and Translation Forum on Drug Discovery , Theresa Wizeman , Robert Giffin

Book information

Year
2009
ISBN
0309120888, 9780309120883
LCC
RA401.A3 W59 2009
Open Library ID
OL24391044M
Language
english
Format
PDF
Filesize
1 MB (1457310 bytes)
Pages
150\151
Topic
Medicine Diseases
Scanned
yes
Time added
2011-06-04 13:46:07

Description

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.

Similar books